Most recently, a comprehensive study highlighted the critical involvement of TGF-β/Smad3 signaling during the process of obesity and demonstrated the beneficial effects of systemic blockade of this signaling from obesity, diabetes, and hepatic steatosis (Yadav et al., 2011). The gene discussed is SMAD3; the disease is obesity due to melanocortin 4 receptor deficiency.